The DOI matches its Crossref record.
A phosphoinositide conversion mechanism for exit from endosomes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other PI(4,5)P2 phosphatases and kinases impact trafficking and degradation of the epidermal growth factor receptor and the transferrin receptor.
“Notably, other PI(4,5)P2 phosphatases (e.g. Lowe oculocerebrorenal syndrome protein (OCRL), also known as INPP5F) and kinases have been reported to impact trafficking and degradation of the epidermal growth factor receptor and the transferrin receptor, which are recycled and degraded in a manner similar to LDLR11–13.”
From Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation (2020) · cites this paper as [12]
Section 1.4 reports that the kinase PI4K2α affects EGFR endosomal trafficking and TfR recycling, and section 1.2.2 describes a role for the PI(4,5)P2 phosphatase OCRL in endocytic membrane traffic. The copy does not establish that OCRL affects EGFR or TfR trafficking or degradation specifically. Its enzyme table also lists INPP5F as Sac2, not OCRL, while PI4K2α synthesizes PI(4)P rather than PI(4,5)P2. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- Balla, T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 93, 1019–1137 (2013) · DOI · Paper page
- Di Paolo, G. & De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651–657 (2006) · DOI · Paper page
- Guo, J. et al. Phosphatidylinositol 4-kinase type IIα is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc. Natl Acad. Sci. USA 100, 3995–4000 (2003) · DOI
- Hammond, G. R., Machner, M. P. & Balla, T. A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi. J. Cell Biol. 205, 113–126 (2014) · DOI · Paper page
- Raiborg, C., Schink, K. O. & Stenmark, H. Class III phosphatidylinositol 3-kinase and its catalytic product PtdIns3P in regulation of endocytic membrane traffic. FEBS J. 280, 2730–2742 (2013) · DOI
- Amoasii, L., Hnia, K. & Laporte, J. Myotubularin phosphoinositide phosphatases in human diseases. Curr. Top. Microbiol. Immunol. 362, 209–233 (2012)
- Dowling, J. J. et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet. 5, e1000372 (2009) · DOI
- Herman, G. E., Finegold, M., Zhao, W., de Gouyon, B. & Metzenberg, A. Medical complications in long-term survivors with X-linked myotubular myopathy. J. Pediatr. 134, 206–214 (1999) · DOI
- Buj-Bello, A. et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl Acad. Sci. USA 99, 15060–15065 (2002) · DOI
- Ribeiro, I., Yuan, L., Tanentzapf, G., Dowling, J. J. & Kiger, A. Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance. PLoS Genet. 7, e1001295 (2011) · DOI
- Hsu, V. W., Bai, M. & Li, J. Getting active: protein sorting in endocytic recycling. Nature Rev. Mol. Cell Biol. 13, 323–328 (2012) · DOI
- Cao, C., Backer, J. M., Laporte, J., Bedrick, E. J. & Wandinger-Ness, A. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol. Biol. Cell 19, 3334–3346 (2008) · DOI
- Cullen, P. J. & Korswagen, H. C. Sorting nexins provide diversity for retromer-dependent trafficking events. Nature Cell Biol. 14, 29–37 (2012) · DOI · Paper page
- Munson, M. J. et al. mTOR activates the VPS34-UVRAG complex to regulate autolysosomal tubulation and cell survival. EMBO J. 34, 2272–2290 (2015) · DOI
- Bago, R. et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem. J. 463, 413–427 (2014) · DOI · Paper page
- Lorenzo, O., Urbé, S. & Clague, M. J. Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions. J. Cell Sci. 119, 2953–2959 (2006) · DOI
- Subramanian, D. et al. Activation of membrane-permeant caged PtdIns(3)P induces endosomal fusion in cells. Nature Chem. Biol. 6, 324–326 (2010) · DOI
- Wang, Y. J. et al. Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell 114, 299–310 (2003) · DOI
- Minogue, S. et al. Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. J. Cell Sci. 119, 571–581 (2006) · DOI
- Mizuno-Yamasaki, E., Medkova, M., Coleman, J. & Novick, P. Phosphatidylinositol 4-phosphate controls both membrane recruitment and a regulatory switch of the Rab GEF Sec2p. Dev. Cell 18, 828–840 (2010) · DOI
- Takahashi, S. et al. Rab11 regulates exocytosis of recycling vesicles at the plasma membrane. J. Cell Sci. 125, 4049–4057 (2012) · DOI · Paper page
- Hertzog, M. & Chavrier, P. Cell polarity during motile processes: keeping on track with the exocyst complex. Biochem. J. 433, 403–409 (2011) · DOI
- Jović, M. et al. Endosomal sorting of VAMP3 is regulated by PI4K2A. J. Cell Sci. 127, 3745–3756 (2014) · DOI
- Hammond, G. R. V. et al. PI4P and PI(4,5)P2 are essential but independent lipid determinants of membrane identity. Science 337, 727–730 (2012) · DOI
- Schmidt, M. R. et al. Regulation of endosomal membrane traffic by a Gadkin/AP-1/kinesin KIF5 complex. Proc. Natl Acad. Sci. USA 106, 15344–15349 (2009) · DOI
- Mössinger, J. et al. Phosphatidylinositol 4-kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch. EMBO Rep. 13, 1087–1094 (2012) · DOI
- Laporte, J. et al. MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat. 15, 393–409 (2000) · DOI
- Laporte, J., Kress, W. & Mandel, J. L. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann. Neurol. 50, 42–46 (2001) · DOI
- Gordon, D. E., Bond, L. M., Sahlender, D. A. & Peden, A. A. A targeted siRNA screen to identify SNAREs required for constitutive secretion in mammalian cells. Traffic 11, 1191–1204 (2010) · DOI
- Hammond, G. R., Schiavo, G. & Irvine, R. F. Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P2 . Biochem. J. 422, 23–35 (2009) · DOI
- Posor, Y. et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. Nature 499, 233–237 (2013) · DOI
- Diesenberg, K., Beerbaum, M., Fink, U., Schmieder, P. & Krauss, M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J. Cell Sci. 128, 397–407 (2015) · DOI
Cited by
Sorted by citations
Phosphoinositides in Control of Membrane Dynamics
Schink, K. O., Tan, K.-W., & Stenmark, H. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125349 · Cited by 283
Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease
Burke, J. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.005 · Cited by 276
Kuijpers, M., Kochlamazashvili, G., Stumpf, A., Puchkov, D., Swaminathan, A., Lucht, M. T., Krause, E., Maritzen, T., Schmitz, D., & Haucke, V. (2021) · Neuron · doi:10.1016/j.neuron.2020.10.005 · Cited by 170
Self-citationQin, Y., Ting, F., Kim, M. J., Strelnikov, J., Harmon, J., Gao, F., Dose, A., Teng, B.-B., Alipour, M. A., Yao, Z., et al. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314033 · Cited by 18
Metadata
- Authors
- Ketel, K., Krauss, M., Nicot, A.-S., Puchkov, D., Wieffer, M., Müller, R., Subramanian, D., Schultz, C., Laporte, J., & Haucke, V.
- Venue
- Nature
- Published
- 2016-01
- Volume
- 529
- Issue
- 7586
- Pages
- 408-412
- ISSN
- 0028-0836
- 1476-4687
- Cited by
- 189
- References
- 0
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review